Nanotechnology is creating new opportunities for fighting disease – from delivering drugs in smart packaging to nanobots powered by the world’s tiniest engines.
The stirrings of a revolution are starting to ripple through hundreds of laboratories. It’s a revolution that aims to result in new medicines – faster and with fewer failures – and it’s being led by three UK universities and three global pharmaceutical companies.
Cambridge-based start-up company Bicycle Therapeutics has recently raised £40 million from a range of investors to bring its cancer drug candidates to clinical trials.
Is the knowledge and scholarship that universities produce relevant to the problems the world faces? In a new essay co-authored with an international group of researchers, Dr Bhaskar Vira of the University of Cambridge Conservation Research Institute (UCCRI) and the Department of Geography argues that in order for science to best serve society and the planet, universities and researchers need to adjust their focus and take responsibility for institutional innovation in five key areas.
Are strict IP policies harming the development of sustainable technologies? In this article for The Conversation, Frank Tietze from the Institute for Manufacturing investigates how the open source approach taken by companies such as Tesla may help the economy and the planet.
A University of Cambridge spin-out company has raised £7 million in new funding, which will help in the development of treatments for liver and lung disease.
With inequalities set to get worse, it’s time to take radical action, says Jaideep Prabhu, Director of Centre for India & Global Business, Cambridge Judge Business School, writing for The Conversation. Could the answer lie in the ‘frugal revolution’ that is already under way?
Cambridge Academy of Therapeutic Sciences aims to create world-leading industry-academia collaborations09 Mar 2017
The Cambridge Academy of Therapeutic Sciences (CATS), a new initiative that aims to establish a world-leading platform for collaboration between academia and industry in the development of therapeutics, will be launched today by the Vice-Chancellor of the University of Cambridge.
Cambridge to partner in major new research centre aimed at tackling challenges in health and life sciences24 Feb 2017
The University of Cambridge is to partner in the new Rosalind Franklin Institute, a £100 million multi-disciplinary science and technology research centre announced by Business Secretary Greg Clark.
A new method for producing conductive cotton fabrics using graphene-based inks opens up new possibilities for flexible and wearable electronics, without the use of expensive and toxic processing steps.